Life ScienceCompany
Rare Pediatric Disease Priority Review Voucher Ownership
Who owns Rare Pediatric Disease Priority Review Voucher?
Rare Pediatric Disease Priority Review Voucher is owned by United Therapeutics. It was acquired on December 28, 2020.
Rare Pediatric Disease Priority Review Voucher Business Overview
Where is Rare Pediatric Disease Priority Review Voucher headquartered?
Rare Pediatric Disease Priority Review Voucher is headquartered in United States.
What sector is Rare Pediatric Disease Priority Review Voucher in?
Rare Pediatric Disease Priority Review Voucher is a life science company.
Life Science M&A Summary in 2020
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.
Join Mergr to view all 290 acquisitions of life science companies in 2020, including 23 acquisitions by private equity firms, and 267 by strategics.